Bank of New York Mellon »

Spyglass Pharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Spyglass Pharma (SGP) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $533k 24k 22.26

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
BlackRock
T. Rowe Price Associates
Vestal Point Capital
Jpmorgan Chase & Co
Deerfield Management Company
Millennium Management
Standard Life Aberdeen
Vanguard Capital Management
Geode Capital Management
Franklin Resources
Affinity Asset Advisors

View all funds holding Spyglass Pharma